Education
About Us
Working with TipRanks
Follow Us
Surgical Science Sweden AB (SE:SUS)
:SUS
Total Valuation
Surgical Science Sweden AB has a market cap or net worth of kr1.27B. The enterprise value is kr1.06B.
Market Capkr1.27B
Enterprise Valuekr1.06B
Share Statistics
Surgical Science Sweden AB has 51,026,237 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding51,026,237
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Surgical Science Sweden AB’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 1.65%.
Return on Equity (ROE)0.02
Return on Assets (ROA)0.01
Return on Invested Capital (ROIC)1.65%
Return on Capital Employed (ROCE)0.02
Revenue Per Employee3.62M
Profits Per Employee243.86K
Employee Count274
Asset Turnover0.21
Inventory Turnover2.02
Valuation Ratios
The current PE Ratio of Surgical Science Sweden AB is 21.3. Surgical Science Sweden AB’s PEG ratio is -0.50.
PE Ratio21.3
PS Ratio1.67
PB Ratio0.39
Price to Fair Value0.39
Price to FCF24.35
Price to Operating Cash Flow21.04
PEG Ratio-0.50
Income Statement
In the last 12 months, Surgical Science Sweden AB had revenue of 992.34M and earned 66.82M in profits. Earnings per share was 1.31.
Revenue992.34M
Gross Profit576.90M
Operating Income108.97M
Pretax Income100.14M
Net Income66.82M
EBITDA192.34M
Earnings Per Share (EPS)1.31
Cash Flow
In the last 12 months, operating cash flow was 79.78M and capital expenditures -40.45M, giving a free cash flow of 39.33M billion.
Operating Cash Flow79.78M
Free Cash Flow39.33M
Free Cash Flow per Share0.77
Dividends & Yields
Surgical Science Sweden AB pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.22
52-Week Price Change-79.33%
50-Day Moving Average29.46
200-Day Moving Average91.54
Relative Strength Index (RSI)66.01
Average Volume (3m)1.61M
Important Dates
Surgical Science Sweden AB upcoming earnings date is May 20, 2026, TBA (Confirmed).
Last Earnings DateFeb 19, 2026
Next Earnings DateMay 20, 2026
Ex-Dividend Date―
Financial Position
Surgical Science Sweden AB as a current ratio of 4.07, with Debt / Equity ratio of 0.04%
Current Ratio4.07
Quick Ratio3.36
Debt to Market Cap<0.01
Net Debt to EBITDA-3.20
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Surgical Science Sweden AB has paid 33.32M in taxes.
Income Tax33.32M
Effective Tax Rate0.33
Enterprise Valuation
Surgical Science Sweden AB EV to EBITDA ratio is 5.43, with an EV/FCF ratio of 15.32.
EV to Sales1.05
EV to EBITDA5.43
EV to Free Cash Flow15.32
EV to Operating Cash Flow13.08
Balance Sheet
Surgical Science Sweden AB has kr616.42M in cash and marketable securities with kr1.63M in debt, giving a net cash position of kr614.80M billion.
Cash & Marketable Securitieskr616.42M
Total Debtkr1.63M
Net Cashkr614.80M
Net Cash Per Sharekr12.05
Tangible Book Value Per Sharekr17.11
Margins
Gross margin is 63.93%, with operating margin of 10.98%, and net profit margin of 6.73%.
Gross Margin63.93%
Operating Margin10.98%
Pretax Margin10.09%
Net Profit Margin6.73%
EBITDA Margin19.38%
EBIT Margin10.98%
Analyst Forecast
The average price target for Surgical Science Sweden AB is kr40.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Targetkr40.00
Price Target Upside-52.66% Downside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast13.40%
EPS Growth Forecast-63.89%